Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA grants breast cancer approval to Roche's Perjeta/Herceptin combo therapy

pharmafileDecember 22, 2017

Tag: Roche , combination therapy

PharmaSources Customer Service